As part of the Q3 revenue release, Clariane confirmed they met the €300m minimum liquidity requirements on the 3rd of November intending to

Read More

Emies (previously Orpea) reported their Q3 revenue numbers, confirming the occupancy and pricing trends already reported by Clariane.  Emies revenue is up

Read More

Clariane only releases top-line revenue numbers in Q1 and Q3, so there are not many new details in their Q3 release.  Revenue has grown in line

Read More

Please find our updated analysis on Clariane here. 

Clariane has executed three of its four pillars of financial restructuring, with the equity raise completed in early July. With some time available to

Read More

The Belgium paper,  De Tijd reported yesterday that the government in the Belgian region of Flanders is considering banning nursing home

Read More

Clariane continues to see operational improvement, with revenue, EBITDA, and occupancy rates all showing year-on-year growth.  On a country-specific basis,

Read More

Clariane has completed their rights issue announced last month raising  c.€237m.  This was fully underwritten so its completion will not impact

Read More

Clariane announced the disposal of its residency service activity, Les Essentielles to Odalys, which is part of the Duval Group.  This business was already categorised as

Read More

Clariane launched their planned rights issue today as part of their Refinancing Plan. This is the second part of the equity raise required, as announced on

Read More

Please find our initial analysis of Clariane here.

With the Company holding an investor Day next Tuesday, this is a preliminary note on Clariane. We have struggled to see what makes people excited about the

Read More

Clariane released their Q1 revenue numbers last night, in line with their guidance. They do not provide any profitability numbers but can reconfirm their FY24 guidance of

Read More